Given the increased expression of MALAT1 in prostate cancer cells, MALAT1 knockout by CRISPR/Cas9 demonstrated that Px459-MALAT1-sgRNA1 and pX459-MALAT1-sgRNA2 vectors inhibited the development and proliferation of prostate cancer DU-145 cells. Here, MALAT1 is linked to prostate carcinoma.